Search Results - "Stavchansky, S A"

Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol) by Kalantzi, L, Reppas, C, Dressman, J B, Amidon, G L, Junginger, H E, Midha, K K, Shah, V P, Stavchansky, S A, Barends, Dirk M

“…Literature data are reviewed on the properties of acetaminophen (paracetamol) related to the biopharmaceutics classification system (BCS). According to the…”
Get more information

Human endothelial cell response to gram-negative lipopolysaccharide assessed with cDNA microarrays by Zhao, B, Bowden, R A, Stavchansky, S A, Bowman, P D

“…To assess the feasibility of using cDNA microarrays to understand the response of endothelial cells to lipopolysaccharide (LPS) and to evaluate potentially…”
Get more information

The cytotoxicity of p-chloro-m-xylenol in primary culture of rat hepatocytes by DAVILA, J. C, DORANTES, A, STAVCHANSKY, S. A, ACOSTA, D

Get full text

Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin by Stavchansky, S A, Kostenbauder, H B, Lubawy, W C

“…The nature of the inhibitory effects of the major metabolite of diphenylhydantoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin (HPPH), on the in vitro metabolism of…”
Get more information

In Vivo Distribution of Carbon-11 Phenytoin and its Major Metabolite, and Their Use in Scintigraphic Imaging by Stavchansky, S. A, Tilbury, R. S, McDonald, J. M, Ting, C. T, Kostenbauder, H. B

“…Curie quantities (0.3--1.5 Ci) of H11CN were used in the synthesis of C-11-tagged phenytoin (C-11.DPH) and 5-(p-hydroxyphenyl)-5-phenylhydantoin (C-11.HPPH),…”
Get full text

Percutaneous absorption of parachlorometaxylenol by Gudipati, Raju M., Stavchansky, Salomon A.

“…The in vitro percutaneous absorption of p-chlorometaxylenol (PCMX), a topical antiseptic, was investigated using pig skin. Solubility studies in aqueous Tween…”
Get full text

Rate of phenytoin accumulation in man: a simulation study by Ludden, T M, Allen, J P, Schneider, L W, Stavchansky, S A

Get more information

A new subcutaneously-implantable reservoir for sustained release of nicotine in the rat by Erickson, C K, Stavchansky, S A, Koch, K I, McGinity, J W

“…A subcutaneously-implantable reservoir for the sustained release of nicotine is described. The device, dubbed INR for Implantable Nicotine Reservoir, is a…”
Get more information

Phenytoin cumulation kinetics by Allen, J P, Ludden, T M, Burrow, S R, Clementi, W A, Stavchansky, S A

“…Four male subjects were given phenytoin orally in single or twice-daily doses. Subjects were on 2 or 3 different dosing rates from 260 to 600 mg phenytoin…”
Get more information

Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin by Stavchansky, S A, Lubawy, W C, Kostenbauder, H B

Get more information

Human pharmacokinetics of ethynyl estradiol 3-sulfate and 17-sulfate by Goldzieher, J W, Mileikowsky, G, Newburger, J, Dorantes, A, Stavchansky, S A

“…Pharmacokinetic parameters of ethynyl estradiol 3-sulfate (EE-3) and 17-sulfate (EE-17) were estimated. Each sulfate was administered orally and intravenously…”
Get more information

Cross inhibition of drug metabolism by drug metabolites. Increase of zoxazolamine paralysis time by the major metabolite of diphenylhydantoin by Lubawy, W C, Kostenbauder, H B, Stavchansky, S A

Get more information